Replimune Gets Third Try at FDA Approval After Makary Departure

Date:




Experimental melanoma drug was rejected twice because the Food and Drug Administration questioned its study design.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Rapper Twista to perform at free Albuquerque community event on Saturday

ALBUQUERQUE, N.M. (KRQE) – Bernalillo County Commission Chair Adriann Barboa...

Ty Herndon Opens Up About Emotional Bonnie Raitt Moment

Ty Herndon was a guest on Taste of Country...

U.S. and Iran Are Close to a Deal

Plus, a plan to put Trump’s face on a...